| Literature DB >> 21792807 |
Abstract
Hip fractures are common and associated with high mortality and morbidity. Patients with hip fractures have a high risk of refractures. Osteoporosis is the underlying cause. A therapy with bisphosphonates is indicated without the need of further diagnostic testing with a bone marrow densitometry.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21792807 DOI: 10.1024/1661-8157/a000614
Source DB: PubMed Journal: Praxis (Bern 1994) ISSN: 1661-8157